FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3121498736> ?p ?o ?g. }

• W3121498736 endingPage "410" @default.
• W3121498736 startingPage "402" @default.
• W3121498736 abstract "Clinical management of cardiac resynchronization therapy (CRT) non-responders is difficult, and their prognosis is poor. The aim of the present study was to evaluate whether treatment with sacubitril/valsartan can improve quality of life (QoL) parameters in these patients.Thirty five non-responders to CRT were included (75 ± 7 years, 28% females, mean left ventricular ejection fraction 28 ± 8%, 54% non-ischemic cardiomyopathy) with maximally optimized drug therapy and New York Heart Association class II-III. They were all on angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers and were switched to sacubitril/valsartan. One week before and 6 months after initiation of the therapy they completed both the Minnesota Living with Heart Failure (MLWHF) and the 12-item Kansas City Cardiomyopathy Questionnaires (KCCQ-12). The primary outcome was the effect of sacubitril/valsartan on the physical, clinical, social and emotional QoL parameters and number of hospitalizations.The mean total scores of both questionnaires improved from baseline to the follow-up visit at 6-months (KCCQ-12 40 ± 10 to 47 ± 10; p < 0.001; MLWHF 40 ± 15 to 29 ± 15; p < 0.001). The best results were seen in the KCCQ-12 total symptom domains (77% improvement), the MLWHF physical domain (81% improvement), and the MLWHF emotional domain (71% improvement). Two patients died during follow-up. The mean number of hospitalizations reduced significantly (1 ± 0.6 vs. 0.5 ± 0.8; p = 0.003) CONCLUSIONS: In CRT non-responders, sacubitril/valsartan significantly improved overall QoL, physical limitations and emotional domains and reduced the number of hospitalizations." @default.
• W3121498736 created "2021-02-01" @default.
• W3121498736 creator A5004294974 @default.
• W3121498736 creator A5010213047 @default.
• W3121498736 creator A5033694660 @default.
• W3121498736 creator A5038152507 @default.
• W3121498736 creator A5041009889 @default.
• W3121498736 creator A5050505215 @default.
• W3121498736 creator A5050868226 @default.
• W3121498736 creator A5058351187 @default.
• W3121498736 creator A5082031422 @default.
• W3121498736 creator A5087471563 @default.
• W3121498736 date "2021-05-25" @default.
• W3121498736 modified "2023-10-18" @default.
• W3121498736 title "Improvement in quality of life with sacubitril/ /valsartan in cardiac resynchronization non-responders: The RESINA (RESynchronization plus an Inhibitor of Neprilysin/Angiotensin) registry" @default.
• W3121498736 cites W1975441982 @default.
• W3121498736 cites W1986817239 @default.
• W3121498736 cites W1987487637 @default.
• W3121498736 cites W1989353963 @default.
• W3121498736 cites W2003402741 @default.
• W3121498736 cites W2057982867 @default.
• W3121498736 cites W2071514857 @default.
• W3121498736 cites W2073186247 @default.
• W3121498736 cites W2075558621 @default.
• W3121498736 cites W2097123331 @default.
• W3121498736 cites W2103150929 @default.
• W3121498736 cites W2134169764 @default.
• W3121498736 cites W2147837104 @default.
• W3121498736 cites W2380447421 @default.
• W3121498736 cites W2413467082 @default.
• W3121498736 cites W2427094903 @default.
• W3121498736 cites W2462375870 @default.
• W3121498736 cites W2614153041 @default.
• W3121498736 cites W2744220975 @default.
• W3121498736 cites W2795886217 @default.
• W3121498736 cites W2885836355 @default.
• W3121498736 cites W2899841238 @default.
• W3121498736 cites W2904458941 @default.
• W3121498736 cites W2905558538 @default.
• W3121498736 cites W2920977137 @default.
• W3121498736 cites W2938564873 @default.
• W3121498736 cites W3011049220 @default.
• W3121498736 cites W3023392435 @default.
• W3121498736 cites W3023683044 @default.
• W3121498736 doi "https://doi.org/10.5603/cj.a2021.0009" @default.
• W3121498736 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8169186" @default.
• W3121498736 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33634846" @default.
• W3121498736 hasPublicationYear "2021" @default.
• W3121498736 type Work @default.
• W3121498736 sameAs 3121498736 @default.
• W3121498736 citedByCount "3" @default.
• W3121498736 countsByYear W31214987362021 @default.
• W3121498736 countsByYear W31214987362023 @default.
• W3121498736 crossrefType "journal-article" @default.
• W3121498736 hasAuthorship W3121498736A5004294974 @default.
• W3121498736 hasAuthorship W3121498736A5010213047 @default.
• W3121498736 hasAuthorship W3121498736A5033694660 @default.
• W3121498736 hasAuthorship W3121498736A5038152507 @default.
• W3121498736 hasAuthorship W3121498736A5041009889 @default.
• W3121498736 hasAuthorship W3121498736A5050505215 @default.
• W3121498736 hasAuthorship W3121498736A5050868226 @default.
• W3121498736 hasAuthorship W3121498736A5058351187 @default.
• W3121498736 hasAuthorship W3121498736A5082031422 @default.
• W3121498736 hasAuthorship W3121498736A5087471563 @default.
• W3121498736 hasBestOaLocation W31214987361 @default.
• W3121498736 hasConcept C104849204 @default.
• W3121498736 hasConcept C126322002 @default.
• W3121498736 hasConcept C159110408 @default.
• W3121498736 hasConcept C164705383 @default.
• W3121498736 hasConcept C2775999527 @default.
• W3121498736 hasConcept C2776034619 @default.
• W3121498736 hasConcept C2776754050 @default.
• W3121498736 hasConcept C2777387769 @default.
• W3121498736 hasConcept C2778198053 @default.
• W3121498736 hasConcept C2778797674 @default.
• W3121498736 hasConcept C2779951463 @default.
• W3121498736 hasConcept C2908929049 @default.
• W3121498736 hasConcept C71924100 @default.
• W3121498736 hasConcept C78085059 @default.
• W3121498736 hasConcept C84393581 @default.
• W3121498736 hasConceptScore W3121498736C104849204 @default.
• W3121498736 hasConceptScore W3121498736C126322002 @default.
• W3121498736 hasConceptScore W3121498736C159110408 @default.
• W3121498736 hasConceptScore W3121498736C164705383 @default.
• W3121498736 hasConceptScore W3121498736C2775999527 @default.
• W3121498736 hasConceptScore W3121498736C2776034619 @default.
• W3121498736 hasConceptScore W3121498736C2776754050 @default.
• W3121498736 hasConceptScore W3121498736C2777387769 @default.
• W3121498736 hasConceptScore W3121498736C2778198053 @default.
• W3121498736 hasConceptScore W3121498736C2778797674 @default.
• W3121498736 hasConceptScore W3121498736C2779951463 @default.
• W3121498736 hasConceptScore W3121498736C2908929049 @default.
• W3121498736 hasConceptScore W3121498736C71924100 @default.
• W3121498736 hasConceptScore W3121498736C78085059 @default.
• W3121498736 hasConceptScore W3121498736C84393581 @default.
• W3121498736 hasIssue "3" @default.
• W3121498736 hasLocation W31214987361 @default.
• W3121498736 hasLocation W31214987362 @default.

• next